Press release
Prescription Stimulants Market – Key Development by 2028 | Novartis AG, Janssen Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Ltd., Independence Pharmaceuticals, Arbor Pharmaceuticals Inc., Sun Pharmaceutical
Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3414
Increasing awareness on prescription stimulants for the treatment of various mental disorders like attention deficit hyperactivity disorders etc. is expected to boost demand for prescription stimulants over the forecast period. Increasing incidence of various disorders like narcolepsy, depression, ADHD, and various acquired brain injuries is also expected to fuel demand for prescription stimulants over the forecast period. Growing popularity of prescription stimulants and increasing funding for researches based on the safe use of these prescription stimulants is also projected to propel market demand for prescription stimulants. However, drug abuse related to prescription stimulants might hinder market growth over the forecast period. The potential for prescription stimulants abuse is increasing owing it to the exponential increase in the availability of these drugs. Also, while prescription stimulants boost mental performance and concentration, it is also linked to causing adverse physiological reactions in the body. Constant abuse can lead to poor health over time. This is anticipated to obstruct market growth for prescription stimulants over the forecast period.
On the basis of Drug Class, Prescription Stimulants Market can be segmented as:
Amphetamines
Methamphetamine
Benzphetamine
Dextroamphetamine
Dexmethylphenidate
Phentermine
Methylxanthine
Methylphenidate
Cholinergics
Others
On the basis of Disease Indication, Prescription Stimulants Market can be segmented as:
Attention-deficit/hyperactivity disorder
Narcolepsy
Depression
Acquired Brain Injuries
Others
On the basis of Distribution Channel, Prescription Stimulants Market can be segmented as:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail-order Pharmacies
Global Prescription Stimulants market has witnessed growth due to increasing availability of these drugs for mental care purposes, often abused for mental pleasure. Prescription stimulants come in capsules or tablets. While the abuse, prescription stimulants are injected in liquid form, swallowed, or snorted. Several researches based on prescription stimulants states that the repeated high doses of prescription stimulants over a short period can cause feelings of paranoia and hostility. Prescription stimulants are used to increase levels of dopamine in the brain. Dopamine is a neurotransmitter which is associated with movement, pleasure, and attention. According to a survey conducted by various drug abuse associations, Prescription stimulants such as Ritalin and Adderall are two of the most frequently abused prescription stimulants by high school seniors, with 6.5% reporting non-medical use of Adderall in 2010, in the United States. Prescription stimulants when used legally for treatment of mental disorders, could help patients tremendously. The medical professionals are advised to monitor all possible negative and possible outcomes when they prescribe these stimulants for treatment purposes.
Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=3414
Geographically, global Prescription Stimulants market is segmented into regions viz. North America, Latin America, Asia Pacific and the Middle East & Africa, Western Europe, Eastern Europe. North America’s prescription stimulants market is expanding because of high rate of FDA approved drugs and increasing availability of these prescription stimulants. The market is expected to remain dominant over the period of forecast due to increase in healthcare expenditure and increasing incidence of ADHD, depression and narcolepsy in the region. Europe’s prescription stimulants market is also expected to grow significantly due to high number of manufacturer presence for prescription stimulants and huge teenage population abusing prescription stimulants for mental pleasure. Asia-Pacific prescription stimulants market is anticipated to grow at a decent rate due to growing awareness and availability of prescription stimulants in the region.
Some of the market participants in the Global Prescription Stimulants market identified across the value chain include: Novartis AG, Janssen Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Ltd., Independence Pharmaceuticals, Arbor Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., UCB, Inc., Tris Pharma, Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, NEOS Therapeutics, Inc., Purdue Pharma L.P., Eli Lilly and Company, and H. Lundbeck A/S.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America (U.S., Canada)
Latin America (Argentina, Mexico, Brazil)
Europe (Germany, Italy, U.K, Spain, France, Russia, Poland)
Asia Pacific Excluding Japan (India, Australia & New Zealand, China, ASEAN)
Japan
Middle East and Africa (GCC, South Africa, Rest Of MEA)
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
For more information on this report, please visit: https://www.factmr.com/report/3414/prescription-stimulants-market
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prescription Stimulants Market – Key Development by 2028 | Novartis AG, Janssen Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Ltd., Independence Pharmaceuticals, Arbor Pharmaceuticals Inc., Sun Pharmaceutical here
News-ID: 1809529 • Views: …
More Releases from Fact.MR
Personal Floatation Devices Market Soars, Expected to Hit US$ 8,014 Million by 2 …
The global personal floatation devices market is expected to be valued at US$ 3,178.7 million in 2022, growing at a CAGR of 9.7% to US$ 8,014 million by the end of 2032.
The personal flotation device market is transitioning from 'distributor-based' sales to direct-to-customer online channels. Catering to the needs of last-mile consumers is a profitable opportunity for manufacturers, and utilising online sales channels can help businesses capitalise on the emerging…
Paper Bottle Market Expected to Expand at 6.2% CAGR by 2033
The Paper Bottles Market is estimated to reach US $ 53.31 million by 2033, with a 6.2% growth rate during the forecast period.
Paper bottle sales are fast increasing, owing to both the growing need for alternatives to plastic bottles and the degradability and eco-friendliness of these containers. Paper bottle sales are expected to rise as demand for beverages rises and effective storage becomes more important.
Get Free Sample Copy of This…
Halloumi Cheese Market Surges Past US$ 1.2 Billion Mark by 2033, Fueled by 10.4% …
It is anticipated that halloumi cheese market will be valued at US$ 445 million in 2023 and surpass US$ 1.2 billion by the end of 2033. It is projected that the worldwide market for halloumi cheese will grow at an astounding rate of 10.4% CAGR till 2033.
Cyprus, a Middle Eastern nation, is the birthplace of halloumi cheese, which has been made there by local farmers for generations. Since this nation…
Cheese Market Is Anticipated To Reach US$ 133 Billion At A CAGR Of 3.7% By 2032: …
In 2022, the global cheese market held a value of US$ 92 billion, with projections indicating a substantial growth trajectory. By the end of 2032, it is anticipated to soar to US$ 133 billion, according to a study conducted by Fact.MR. The research suggests that the worldwide demand for cheese is expected to experience a steady increase, with a compound annual growth rate (CAGR) of 3.7% forecasted through the year…
More Releases for Prescription
Prescription Spectacles Market Growth Trajectory 2022-28
According to Precision Business Insights (PBI), the latest report, the Prescription Spectacles market is expected to be valued at USD 43,584.1 million in 2022, growing at a 3.1% CAGR from 2022 to 2028. Growing rely on electronic devices like mobile, laptops, computers for day-to-day work and entertainment and too much involvement at glaring at the screen even in the night time coming with the side effect of ocular problems. As…
SRI Format Romania e-Prescription: The first e-prescription that can be used thr …
The transeuropean online doctor service www.private-GP.org has become the first EU-wide user of the "SRI Format Romania" for e-prescriptions. Convenient and secure for patients, simple and user-friendly for pharmacies.
"This means that privateGP doctors can make things even easier for their patients and also provide better security for pharmacies," emphasizes Dr. Martin Kramer, who is responsible for introducing the new technology at privateGP. "The combination of safety and functionality is impressive…
Electronic Prescription Software Market Insights
The Global Electronic Prescription Software Market covers unequivocal information regarding the development rate, request estimates, motorists, limitations, future-grounded demand, and profit during the cast period. The Global Electronic Prescription Software Market consists of data accumulated from multitudinous primary and secondary sources. This information has been vindicated and validated by the assiduity judges, therefore furnishing significant perceptivity to the experimenters, judges, directors, and other assiduity professionals. This document further helps in…
Prescription/Rx Sunglass Market 2022 | Detailed Report
The Prescription/Rx Sunglass research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,…
Latest Medicare Prescription Drug Plan Data Reported
Some 48 million Americans are enrolled in Medicare prescription drug plans according to the latest data reported by the American Association for Medicare Supplement Insurance.
“Prescription drug plan coverage is one of the most important benefits valued by seniors on Medicare,” states Jesse Slome, director of the Medicare advocacy organization. “Individuals have enormous choice today and selecting the right prescription drug plan coverage can be a significant money saver.”
According to…
The Best Prescription Safety Sunglasses – New Features
08/10/2021 – Middlesex, NJ: Prescription safety sunglasses can be an immensely valuable accessory in your work life. They can protect you from all kinds of elements when you’re on the job, including dust, dirt, sand, and other foreign materials. Not only that, but prescription safety sunglasses can be extremely stylish. When you are working in challenging conditions, you want your eyewear to be both functional and aesthetically pleasing.
However, if you…
